The Livmor Halo System is a continuous heart monitoring system worn on the wrist, and it can enhance detection for intermittent or asymptomatic forms of atrial fibrillation, the release said. The Samsung-run device can be worn daily and is completely noninvasive.
“The FDA 510(k) clearance of our LIVMOR Halo … is a significant milestone for LIVMOR and serves as a foundational cornerstone in our Samsung-based digital health platform,” Ken Persen, founder and CEO of Livmor, said in a statement. “This is [a] major step toward achieving our vision of a transformative patient-provider ecosystem that more proactively prevents, detects and manages chronic conditions.”
Read the full report here.
More articles on surgery centers:
4 new joint-venture ASCs — September 2020
Work begins on new ASC in Arizona — 3 details
SCA centers added 1,000+ new surgeons in 2020 so far: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
